Nearly every peptide sold online carries a line saying "for research use only" or "not for human consumption." It is worth understanding exactly what that phrase does, because it is routinely read as something it is not.
What it is
It is a statement of intended use made by the seller. Genuine research reagents carry such labelling because they are sold for laboratory work and have not been manufactured to the standards required for medicines.
What it is not
- Not a safety assessment. No regulator has reviewed the product.
- Not a quality standard. It says nothing about purity, sterility or whether the vial contains what the label claims.
- Not a legal shield. Regulators look at the whole context of a sale, not the disclaimer.
How the FDA reads it
In March 2026 the FDA issued warning letters to seven sellers of GLP-1 and related peptides, naming retatrutide among the products. The letters set out what the agency treats as evidence that a product is actually intended for human use, regardless of the disclaimer:
- Weight-loss, appetite or blood sugar claims on the site
- Usage-style wording, imagery and customer testimonials
- Bundled injection supplies such as bacteriostatic water
- How the catalogue is organised
In one letter the agency stated that evidence from the seller’s website established that the products were intended to be drugs for human use. The products were classified as unapproved new drugs.
The wider pressure
In October 2026 a US senator wrote to the FDA urging a broader crackdown on research-use-only labelling, citing a 265% increase in retatrutide-related poison centre cases in the first four months of 2026 compared with the preceding four months, and federal charges against a Florida seller whose product contained no retatrutide at all.
For a buyer, the practical consequence is simple: the disclaimer transfers risk rather than reducing it. Nobody has checked the product, and no regulator stands behind it.